Akihiro Hashimoto
- Molecular Biology
- Oncology
- Pulmonary and Respiratory Medicine
- Organic Chemistry
- Pharmacology top 10%
- Co-authors
- Kazuhiko YonekuraKenner C. RiceMilind DeshpandeJason A. WilesYoshimi AoyagiBarton J. BradburyJane A. ThanassiKazutaka Miyadera
- Topics
- Cancer therapeutics and mechanisms (6 papers)Lung Cancer Treatments and Mutations (5 papers)Synthesis and biological activity (4 papers)
- Cited by
- ToxicologyMolecular MedicineOncology
- Journals
- BloodPLoS ONECancer Research
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Akihiro Hashimoto
31 papers receiving 589 citations
Peers
Comparison fields: 5 of 77
- Molecular Biology 329
- Oncology 207
- Pulmonary and Respiratory Medicine 150
- Organic Chemistry 117
- Pharmacology 107
Countries citing papers authored by Akihiro Hashimoto
This map shows the geographic impact of Akihiro Hashimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihiro Hashimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihiro Hashimoto more than expected).
Fields of papers citing papers by Akihiro Hashimoto
This network shows the impact of papers produced by Akihiro Hashimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihiro Hashimoto. The network helps show where Akihiro Hashimoto may publish in the future.
Co-authorship network of co-authors of Akihiro Hashimoto
This figure shows the co-authorship network connecting the top 25 collaborators of Akihiro Hashimoto. A scholar is included among the top collaborators of Akihiro Hashimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akihiro Hashimoto. Akihiro Hashimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 10 | |
| 6 | 55 | |
| 7 | 12 | |
| 8 | 70 | |
| 9 | 15 | |
| 10 | 30 | |
| 11 | 40 | |
| 12 | TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect. | 29 |
| 13 | 22 | |
| 14 | 41 | |
| 15 | The induction of apoptosis and inhibition of AP-1 activity by TAC-101 (4-[3,5-bis(trimethylsilyl) benzamido] benzoic acid) may result in life prolonging effect in animals bearing metastasizing cancer. | 9 |
| 16 | 25 | |
| 17 | [Anti-angiogenic activities of UFT and its metabolites, GHB and GBL, in the dorsal air sac (DAS) model in mice]. | 2 |
| 18 | 8 | |
| 19 | 22 | |
| 20 | 25 |
About Akihiro Hashimoto
Akihiro Hashimoto is a scholar working on Hepatology, Oncology and Cancer Research, having authored 33 papers that have together received 617 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Synthesis and biological activity (4 papers). The work is most often cited by research in Toxicology (38 citations), Molecular Medicine (40 citations) and Oncology (207 citations). Akihiro Hashimoto has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Kazuhiko Yonekura, Kenner C. Rice, Milind Deshpande, Jason A. Wiles, Yoshimi Aoyagi, Barton J. Bradbury, Jane A. Thanassi, Kazutaka Miyadera, Michael J. Pucci and Robert Fecik. Their work appears in journals such as Blood, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.